Form 4: abrdn World Healthcare Fund Director Acquires Additional Shares

Kathleen Goetz, a director of abrdn World Healthcare Fund, purchased 200 shares of common stock at $12.53 per share on April 9, 2024.

Summary

• On April 9, 2024, Kathleen Goetz, a director of abrdn World Healthcare Fund (THW), acquired 200 shares of common stock.
• The purchase price was $12.53 per share.
• Following the transaction, Goetz directly owns 1,017.377 shares of the fund's common stock.
• The filing also includes a Power of Attorney, dated October 26, 2023, authorizing individuals to act on Goetz's behalf for Section 16 filings.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but the quantity is relatively small and may not be highly significant.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Directors' transactions are closely watched by investors as they can provide insights into the company's performance and future expectations within the healthcare industry.

Comparison to Industry Standards

• Comparing insider transactions to those of directors at similar healthcare funds (e.g., Tekla Healthcare Opportunities Fund, BlackRock Health Sciences Trust) can provide context on the significance of this purchase.
• Industry benchmarks for insider ownership as a percentage of outstanding shares can also be used to assess the materiality of Goetz's holdings.

Stakeholder Impact

• The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates